Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

Sponsor
Nourhan M.Aly (Other)
Overall Status
Completed
CT.gov ID
NCT04308863
Collaborator
Alexandria University (Other)
30
1
2
25.2
1.2

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the clinical and radiographic outcomes of Chitosan scaffold and Mineral trioxide aggregate (MTA) when used as pulpotomy agents in mature permanent teeth with irreversible pulpitis.

Condition or Disease Intervention/Treatment Phase
  • Drug: Chitosan scaffold/ MTA pulp dressing material
  • Drug: MTA pulp dressing material
Phase 2

Detailed Description

Thirty permanent mandibular molars of patients with signs and symptoms of irreversible pulpitis will be selected. They will be randomly allocated into two groups, Group 1(Chitosan scaffold/ MTA pulp dressing materials), Group 2 (MTA pulp dressing material). A single visit full pulpotomy procedure will be carried out. Chitosan scaffold and / or MTA will be used as the pulp dressing materials. The teeth will be then restored with base of Glass ionomer cement followed by composite restoration.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Thirty permanent mandibular molars of patients with signs and symptoms of irreversible pulpitis will be selected. They will be randomly allocated into two groups, Group 1(Chitosan scaffold/ MTA pulp dressing materials), Group 2 (MTA pulp dressing material).Thirty permanent mandibular molars of patients with signs and symptoms of irreversible pulpitis will be selected. They will be randomly allocated into two groups, Group 1(Chitosan scaffold/ MTA pulp dressing materials), Group 2 (MTA pulp dressing material).
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
Actual Study Start Date :
Nov 15, 2018
Actual Primary Completion Date :
Oct 30, 2020
Actual Study Completion Date :
Dec 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chitosan scaffold/ MTA pulp dressing material

Drug: Chitosan scaffold/ MTA pulp dressing material
Chitosan 3-D porous scaffold will be prepared. The chitosan scaffolds will be examined with the Scanning electron microscopy (SEM) to analyze the surface of the chitosan scaffolds. The scaffolds will be sterilized by Ethylene oxide and stored until further use. A piece of 2-mm thick chitosan scaffold will be gently placed onto the pulp chamber floor and covering the canal orifices, and then a 2-3 mm thick layer of fast setting EndoCem Zr MTA will be applied onto the chitosan scaffold and will be gently condensed with moistened cotton pellet to attain adequate thickness which will be confirmed radiographically. MTA will be allowed to set for 4-5 mins.

Active Comparator: MTA pulp dressing material

Drug: MTA pulp dressing material
MTA will be gently placed over the fresh pulp wound using an MTA carrier to a thickness of 2-3 mm. It will be condensed lightly with moistened cotton pellet to attain adequate thickness and confirmed radiographically. MTA will be allowed to set for 4-5 mins.

Outcome Measures

Primary Outcome Measures

  1. Pain Assessment [one week]

    Postoperative pain will be recorded on Numerical Rating Pain Scale (NRS) that will be given to the patient to record his pain intensity in the range between 0-10, until the seventh day after treatment. Pain on the NRS will be further categorized as: No pain (0), Mild (1-3), Moderate (4-6), and Severe (7-10) pain.

  2. Mineralization Activity [baseline]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  3. Mineralization Activity [1 month]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  4. Mineralization Activity [3 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  5. Mineralization Activity [6 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  6. Mineralization Activity [9 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  7. Mineralization Activity [12 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization

  8. Root Canal Obliteration [baseline]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  9. Root Canal Obliteration [1 month]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  10. Root Canal Obliteration [3 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  11. Root Canal Obliteration [6 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  12. Root Canal Obliteration [9 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  13. Root Canal Obliteration [12 months]

    Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration

  14. Internal Root Resorption [baseline]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

  15. Internal Root Resorption [1 month]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

  16. Internal Root Resorption [3 months]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

  17. Internal Root Resorption [6 months]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

  18. Internal Root Resorption [9 months]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

  19. Internal Root Resorption [12 months]

    Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption

Secondary Outcome Measures

  1. Changes in the dental pulp in treated teeth [6 months]

    This will be performed in comparison to a non-affected tooth with clinical vitality and without any additional past treatment. All observers will analyze the images using the following rating scale regarding to alterations of signal intensity of the dental pulp at nT1w, fsT1w, and fsT2w at distinct time intervals (1 = no signs of alterations of signal intensity of the dental pulp between affected and non-affected teeth, 2 = slightly alterations of signal intensity of the dental pulp between affected and nonaffected teeth, and 3 = obvious alterations of signal intensity of the dental pulp between affected and nonaffected teeth)

  2. Peri-radicular/furcal pathosis [12 months]

    Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of any peri-radicular/furcal pathosis

  3. Internal and external root resorption [12 months]

    Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of internal or external root resorption

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants free from any systemic disease.

  • Deep caries in a permanent lower molar with mature roots.

  • Probing pocket depth and mobility within normal limits.

  • No signs of pulpal necrosis including sinus tract or swelling.

  • Vital bleeding pulp tissue should be present in all canals after complete pulpotomy.

  • The tooth is restorable.

  • Clinical diagnosis of symptomatic irreversible pulpitis based on subjective and objective examinations:

  • Subjective examination: Patients complaining of intermittent or spontaneous pain or pain exacerbated by dramatic temperature changes especially to cold stimuli and lasting for a few seconds to several hours.

  • Objective examination:

  • Clinical examination: Teeth that will experience immediate, excruciatingly painful sensation as soon as the cold stimulus is placed on and which may last for a while even after the removal of the stimulus.

  • Radiographic examination: Preoperative radiographs will be taken using a paralleling device.

  • The periapical index developed by Orstavik et al. (1986)(35) will be used to score cases with periapical rarefaction during diagnosis and follow-up periods. It consists of five categories:

  1. Normal periapical structures.

  2. Small changes in bone structures.

  3. Change in bone structure with mineral loss.

  4. Periodontitis with well-defined radiolucent area.

  5. Severe periodontitis with exacerbating features. Score 1 and 2 are considered healthy, score 3-5 are considered diseased

  • The teeth that will be included should have score 1 or 2.
Exclusion Criteria:
  • Negative response to cold testing.

  • No pulp exposure after caries excavation.

  • Bleeding could not be controlled in 10 minutes after 2.5% NaOCl

  • Absence of bleeding from any of the canals.

  • Teeth with radiographic signs of internal resorption.

  • Pulpal calcifications.

  • Participants with stainless-steel wires and brackets.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Dentistry, Alexandria University Alexandria Egypt 21512

Sponsors and Collaborators

  • Nourhan M.Aly
  • Alexandria University

Investigators

  • Principal Investigator: Maha T Aboul Kheir, M.Sc, Faculty of Dentistry, Alexandria University, Egypt
  • Study Director: Rania M ElBackly, PhD, Faculty of Dentistry, Alexandria University, Egypt
  • Study Chair: Raef Sherif, PhD, Faculty of Dentistry, Alexandria University, Egypt
  • Study Chair: Yasser Elkamary, European Egyptian Pharmaceutical Industries, Pharco Corporation, Alexandria, Egypt
  • Study Chair: Nayera Mokhless, PhD, Faculty of Dentistry, Alexandria University, Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Nourhan M.Aly, Instructor of Dental Public Health and Statistician, University of Alexandria
ClinicalTrials.gov Identifier:
NCT04308863
Other Study ID Numbers:
  • Chitosan vs MTA
First Posted:
Mar 16, 2020
Last Update Posted:
May 19, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2022